Similar articles

• Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.

  Ranke MB. Ranke MB. Trends Endocrinol Metab. 2005 May-Jun;16(4):190-7. doi: 10.1016/j.tem.2005.03.011. Trends Endocrinol Metab. 2005. PMID: 15860416 Review.
• Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.

  Cutfield WS, Lundgren F. Cutfield WS, et al. Horm Res. 2009 Jan;71 Suppl 1:39-45. doi: 10.1159/000178036. Epub 2009 Jan 21. Horm Res. 2009. PMID: 19153504
• Advances in pediatric growth hormone therapy: IGF-I-based dosing.

  Pawlikowska-Haddal A, Cohen P. Pawlikowska-Haddal A, et al. Indian Pediatr. 2006 Jul;43(7):577-81. Indian Pediatr. 2006. PMID: 16891676 No abstract available.
• Treatment approaches for growth failure.

  Root AW. Root AW. Pediatr Endocrinol Rev. 2008 Sep;6(1):51-2. Pediatr Endocrinol Rev. 2008. PMID: 18806726 No abstract available.
• Partial growth hormone insensitivity.

  Johnston LB, Savage MO. Johnston LB, et al. J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:251-7. J Pediatr Endocrinol Metab. 1999. PMID: 10698589 Review.